Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdditions show that no longer looking for participants and the record revision updated to v3.6.0; Deletion removes the previous revision v3.5.5 from the history.SummaryDifference0.4%

- Check20 days agoChange DetectedRevision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a new site release version. This update is metadata-related and does not modify the study record content.SummaryDifference0.1%

- Check42 days agoChange DetectedA new Revision tag v3.5.4 appears, replacing the previous revision tag v3.5.3 as part of the site's release notes.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page footer now shows Revision: v3.5.3 instead of v3.5.2, indicating a new release/version of the ClinicalTrials.gov site. This update does not modify the study data or visible content on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the revision history.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision v3.5.0 was added and the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.